Boehringer Ingelheim pleased with 2013 financial year
Richard Mole Appointed President and Chief Executive Officer of Boehringer Ingelheim (Canada) Ltd.
Response to Recent Media Coverage of Pradaxa® (dabigatran etexilate mesylate)
New Approval for Metacam® 20mg/mL in Pigs for Locomotor Disorders
3 vaccines in 1 shot. Ingelvac® 3FLEX™ now contains a new bottle for Ingelvac MycoFLEX® which simplifies mixing with Ingelvac CircoFLEX® & Ingelvac® PRRS MLV.